5Chhaiya S B, Mehta D S, Kataria B C. Ivermectin: Pharmacology and therapeutic applications[J]. Inter- national Journal of Basic : Clinical Pharmacolo- gy, 2012,1 (3) : 132-139.
6Shakeel F, Baboota S, Ahuja A. Celecoxib nanoemul- sion for transdermal drug delivery: Characterization and in vitro evaluation[J]. Journal of Dispersion Science and Technology ,2009,30(6):834 842.
7Shafiq S, Shakeel F, Talegaonkar S. Development and bioavailability assessment of rarnipril nanoemulsion formulation[J]. European Journal of Pharmaceutics and Biopharmaceutics ,2007,66(2) :227-243.
8Shakeel F,Shafiq S, Haq N. Nanoemulsions as poten- tial vehicles for transdermal and dermal delivery of hydrophobic compounds [J]. Informa Healthcare, 2012,9(8) :95a-974.
9Zhou H,Wan J L,Wu L,et al. A new strategy for en- hancing the oral bioavailability of drugs with poor wa- ter solubility and low liposolubility based on phospho- lipid complex and supersaturated SEDDS[J]. PLoS 0ne,2013,8(12) :e84530.
10Dixit N, Kohli K, Baboota S. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovas- cular drug[J]. PDA Journal of Pharmaceutical Sci- ence and Technology, 2008,62 (1) : 46-55.
